Healthcare provider profile · identity verified

Jorge E Ruiz Diaz, M.D.

Allopathic & Osteopathic Physicians|Internal Medicine · ADJUNTAS, PR · NPI 1215950985

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jorge E Ruiz Diaz, M.D. received $97.74 in general payments during 2025 across 3 reported records.

GlaxoSmithKline, LLC. accounted for 52.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 75 claims for Jardiance by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNJARDY as an associated drug or biological on 33 records involving 33 distinct recipient NPIs. Public Medicare Part D data also shows 21 claims for Synjardy by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Shingrix by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$97.74

3 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$51.30	52.5%	1	2025
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$25.04	25.6%	1	2025
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$21.40	21.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$97.74	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$25.04	1	2025
Source payment records 2025-08-13 · Boehringer Ingelheim Pharmaceuticals, Inc. · $25.04 · Open Payments source
General - Angioplasty Normalized: general angioplasty	Device	Boston Scientific Corporation	$21.40	1	2025
Source payment records 2025-03-21 · Boston Scientific Corporation · $21.40 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	75	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	75	28
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	SYNJARDY open payments reported associated product	CMS Open Payments — General Payments 33 supporting records · 33 recipient NPIs · example record 1222725005	Synjardy · 2024 Exact normalized brand match · 1 Part D row	21	suppressed by CMS
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	SHINGRIX open payments reported associated product	CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452	Shingrix · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	2161	490
Famotidine	Famotidine	1939	422
Atorvastatin Calcium	Atorvastatin Calcium	1128	371
Losartan Potassium	Losartan Potassium	930	307
Levothyroxine Sodium	Levothyroxine Sodium	890	129
Synthroid	Levothyroxine Sodium	886	130
Lisinopril	Lisinopril	868	292
Pantoprazole Sodium	Pantoprazole Sodium	866	194
Simvastatin	Simvastatin	846	264
Omeprazole	Omeprazole	805	174
Hydrochlorothiazide	Hydrochlorothiazide	739	189
Metformin Hcl	Metformin Hcl	718	231
Tamsulosin Hcl	Tamsulosin Hcl	637	129
Alendronate Sodium	Alendronate Sodium	554	130
Furosemide	Furosemide	550	131
Amlodipine Besylate	Amlodipine Besylate	525	204
Metoprolol Succinate	Metoprolol Succinate	524	142
Montelukast Sodium	Montelukast Sodium	513	130
Clopidogrel	Clopidogrel Bisulfate	498	96
Baclofen	Baclofen	468	183
Meloxicam	Meloxicam	434	209
Glimepiride	Glimepiride	414	132
Temazepam	Temazepam	397	61
Carvedilol	Carvedilol	389	108
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	361	158
Metoprolol Tartrate	Metoprolol Tartrate	356	81
Donepezil Hcl	Donepezil Hcl	333	71
Lantus	Insulin Glargine,hum.Rec.Anlog	325	64
Rosuvastatin Calcium	Rosuvastatin Calcium	324	117
Fenofibrate	Fenofibrate	305	107
Tizanidine Hcl	Tizanidine Hcl	299	136
Clonazepam	Clonazepam	295	71
Farxiga	Dapagliflozin Propanediol	278	71
Finasteride	Finasteride	273	55
Isosorbide Mononitrate Er	Isosorbide Mononitrate	268	58
Levoxyl	Levothyroxine Sodium	236	32
Eliquis	Apixaban	226	45
Azithromycin	Azithromycin	209	173
Allopurinol	Allopurinol	193	44
Sertraline Hcl	Sertraline Hcl	186	36
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	181	26
Meclizine Hcl	Meclizine Hcl	181	62
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	179	106
Tramadol Hcl	Tramadol Hcl	178	53
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	169	61
Pentoxifylline	Pentoxifylline	162	30
Nabumetone	Nabumetone	160	69
Atenolol	Atenolol	156	56
Spironolactone	Spironolactone	155	40
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	152	38
Hydralazine Hcl	Hydralazine Hcl	140	53
Trazodone Hcl	Trazodone Hcl	137	34
Duloxetine Hcl	Duloxetine Hcl	132	38
Fluticasone Propionate	Fluticasone Propionate	132	65
Albuterol Sulfate Hfa	Albuterol Sulfate	125	61
Pregabalin	Pregabalin	119	26
Levofloxacin	Levofloxacin	116	98
Metoclopramide Hcl	Metoclopramide Hcl	115	40
Dexamethasone	Dexamethasone	107	81
Zolpidem Tartrate	Zolpidem Tartrate	107	22
Fluoxetine Hcl	Fluoxetine Hcl	106	30
Fenofibrate	Fenofibrate Nanocrystallized	105	37
Fluconazole	Fluconazole	103	82
Albuterol Sulfate	Albuterol Sulfate	102	83
Latanoprost	Latanoprost	101	33
Triamcinolone Acetonide	Triamcinolone Acetonide	101	84
Levetiracetam	Levetiracetam	100	16
Glipizide	Glipizide	99	29
Tradjenta	Linagliptin	99	26
Lorazepam	Lorazepam	97	21
Oxybutynin Chloride Er	Oxybutynin Chloride	97	22
Doxazosin Mesylate	Doxazosin Mesylate	95	27
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	94	26
Xarelto	Rivaroxaban	94	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	92	71
Ezetimibe	Ezetimibe	92	40
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	92	28
Nifedipine Er	Nifedipine	90	32
Alprazolam	Alprazolam	89	16
Esomeprazole Magnesium	Esomeprazole Magnesium	88	16
Memantine Hcl	Memantine Hcl	86	15
Oxybutynin Chloride	Oxybutynin Chloride	82	26
Chlorthalidone	Chlorthalidone	80	18
Humalog	Insulin Lispro	77	20
Janumet	Sitagliptin Phos/Metformin Hcl	77	24
Cilostazol	Cilostazol	76	17
Irbesartan	Irbesartan	76	25
Jardiance	Empagliflozin	75	28
Brilinta	Ticagrelor	65	17
Lansoprazole	Lansoprazole	61	13
Dicyclomine Hcl	Dicyclomine Hcl	60	32
Isosorbide Dinitrate	Isosorbide Dinitrate	60	11
Quetiapine Fumarate	Quetiapine Fumarate	60	23
Anastrozole	Anastrozole	59	13
Breo Ellipta	Fluticasone/Vilanterol	59	18
Diclofenac Sodium	Diclofenac Sodium	59	47
Ciprofloxacin Hcl	Ciprofloxacin Hcl	58	48
Methimazole	Methimazole	58	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	58	13
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	57	13
Vitamin D2	Ergocalciferol (Vitamin D2)	57	21
Calcitriol	Calcitriol	56	12
Insulin Syringe	Syringe And Needle,insulin,1ml	56	22
Theophylline Er	Theophylline Anhydrous	56	14
Warfarin Sodium	Warfarin Sodium	55	suppressed
Sucralfate	Sucralfate	54	23
Clorazepate Dipotassium	Clorazepate Dipotassium	53	12
Bumetanide	Bumetanide	51	24
Nystatin	Nystatin	49	31
Enalapril Maleate	Enalapril Maleate	48	18
Paroxetine Hcl	Paroxetine Hcl	48	12
Terazosin Hcl	Terazosin Hcl	48	14
Amitriptyline Hcl	Amitriptyline Hcl	47	suppressed
Mirtazapine	Mirtazapine	47	11
Nitroglycerin	Nitroglycerin	47	33
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	47	12
Estazolam	Estazolam	46	suppressed
Clotrimazole	Clotrimazole	45	30
Etodolac	Etodolac	45	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	45	42
Topiramate	Topiramate	45	suppressed
Cefadroxil	Cefadroxil	44	38
Propranolol Hcl	Propranolol Hcl	44	suppressed
Amiodarone Hcl	Amiodarone Hcl	43	suppressed
Mometasone Furoate	Mometasone Furoate	43	30
Buspirone Hcl	Buspirone Hcl	41	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	37	33
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	37	12
Sildenafil Citrate	Sildenafil Citrate	37	suppressed
Diazepam	Diazepam	36	suppressed
Metronidazole	Metronidazole	36	28
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	36	29
Ibandronate Sodium	Ibandronate Sodium	35	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	34	suppressed
Ciclopirox	Ciclopirox	33	30
Digoxin	Digoxin	33	suppressed
Mupirocin	Mupirocin	33	28
Sure Comfort	Syringe And Needle,insulin,1ml	33	12
Humulin R	Insulin Regular, Human	32	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	32	20
Risperidone	Risperidone	32	suppressed
Prednisone	Prednisone	31	16
Xigduo Xr	Dapaglifloz Propaned/Metformin	31	suppressed
Metformin Hcl Er	Metformin Hcl	30	suppressed
Methylprednisolone	Methylprednisolone	30	27
Ondansetron Hcl	Ondansetron Hcl	29	25
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	28	suppressed
Methotrexate	Methotrexate Sodium	28	suppressed
Acebutolol Hcl	Acebutolol Hcl	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Fluorometholone	Fluorometholone	27	suppressed
Jentadueto	Linagliptin/Metformin Hcl	27	suppressed
Raloxifene Hcl	Raloxifene Hcl	27	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Gemfibrozil	Gemfibrozil	26	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Timolol Maleate	Timolol Maleate	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Acyclovir	Acyclovir	25	16
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	13
Naproxen	Naproxen	24	18
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	24	20
Tolterodine Tartrate	Tolterodine Tartrate	24	suppressed
Carbamazepine Er	Carbamazepine	23	suppressed
Colchicine	Colchicine	23	13
Keppra	Levetiracetam	23	suppressed
Novolog	Insulin Aspart	23	suppressed
Verapamil Er	Verapamil Hcl	23	suppressed
Indapamide	Indapamide	22	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	22	suppressed
Loperamide	Loperamide Hcl	22	16
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	22	suppressed
Acetic Acid	Acetic Acid	21	18
Atrovent Hfa	Ipratropium Bromide	21	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	21	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Metolazone	Metolazone	21	suppressed
Premarin	Estrogens, Conjugated	21	suppressed
Ranolazine Er	Ranolazine	21	suppressed
Synjardy	Empagliflozin/Metformin Hcl	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Lumigan	Bimatoprost	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	20	suppressed
Humalog Mix 50-50 Kwikpen	Insulin Lispro Protamin/Lispro	19	suppressed
Humulin N	Insulin Nph Human Isophane	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	19	11
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	11
Valsartan	Valsartan	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Enulose	Lactulose	16	11
Ketoconazole	Ketoconazole	16	12
Lactulose	Lactulose	16	12
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	14
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Potassium	Diclofenac Potassium	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Glyxambi	Empagliflozin/Linagliptin	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	14	14
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Galantamine Er	Galantamine Hbr	13	suppressed
Potassium Chloride	Potassium Chloride	13	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	12	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Estradiol	Estradiol	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pramipexole Er	Pramipexole Di-Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$97.74 · 3 records	GlaxoSmithKline, LLC.	General - Angioplasty, JARDIANCE	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error